← Eichor
Study identifier: NCT05486884 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Mean Arterial Pressure After Out-of-hospital Cardiac Arrest

Condition: Cardiac Arrest · Out-of-hospital Cardiac Arrest (OHCA)  ·  Sponsor: Centre Hospitalier le Mans

PhaseNA
Planned participants1380
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Out-of-hospital cardiac arrest is a public health problem for which overall survival is below 10%. Post-cardiac arrest syndrome is the principal cause of death in intensive care units (ICU), due to refractory shock or brain injuries secondary to anoxia. Brain anoxia is responsible for severe neurological sequelae that may be aggravated by cerebral hypoperfusion during the first few hours after the return of spontaneous circulation. Current recommendations are to ensure that arterial blood pressure is sufficient for the perfusion of organs, but no minimum threshold mean arterial pressure (MAP) has been defined. In practice, most teams target a MAP of at least 65 mmHg. Several observational studies have shown a correlation between MAP and neurological prognosis, patients with a higher initial MAP having a better outcome. Recent pilot studies have demonstrated the feasibility of increasing the target MAP after cardiac arrest, but conflicting results have been obtained concerning patient prognosis. These findings may be explained by changes to the autoregulation of the brain after cardiac arrest, with a shift of the curve towards the right, or its abolition. Cerebral blood flow is dependent on MAP, and a target MAP of 65 mmHg for these patients may result in insufficient brain perfusion. Conversely, a too high MAP might cause brain lesions due to vasogenic edema, hemorrhagic complications or excess perfusion in conditions of diminished brain metabolism. An interventional study is…

This description comes directly from the study's public registry record.

Talk to the study team

Christelle JADEAU  ·  +33244710781  ·  cjadeau@ch-lemans.fr

Nicolas CHUDEAU  ·  +33243432458  ·  nchudeau@ch-lemans.fr

Always discuss trial participation with your own doctor first.

Locations (27)

CHU Brest - Hôpital de La Cavale BlancheBrest, FranceRecruiting
CH BriveBrive-la-Gaillarde, FranceRecruiting
CHU CaenCaen, FranceRecruiting
CH CholetCholet, FranceRecruiting
CH DieppeDieppe, FranceRecruiting
CHU Dijon - Hôpital F. MitterrandDijon, FranceRecruiting
CHD VendéeLa Roche-sur-Yon, FranceRecruiting
CH VersaillesLe Chesnay, FranceNot Yet Recruiting
Centre Hospitalier Du MansLe Mans, FranceRecruiting
CH Dr SchaffnerLens, FranceRecruiting
CHU LilleLille, FranceRecruiting
CHU LimogesLimoges, FranceRecruiting

+ 15 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05486884